Your browser doesn't support javascript.
loading
Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?
Eriksen, J; Davidkin, I; Kafatos, G; Andrews, N; Barbara, C; Cohen, D; Duks, A; Griskevicius, A; Johansen, K; Bartha, K; Kriz, B; Mitis, G; Mossong, J; Nardone, A; O'Flanagan, D; DE Ory, F; Pistol, A; Theeten, H; Prosenc, K; Slacikova, M; Pebody, R.
Afiliação
  • Eriksen J; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Davidkin I; National Institute for Health and Welfare (THL), Helsinki, Finland.
  • Kafatos G; Health Protection Agency Health Protection Services Colindale, London, UK.
  • Andrews N; Health Protection Agency Health Protection Services Colindale, London, UK.
  • Barbara C; Mater Dei Hospital, Malta.
  • Cohen D; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Israel.
  • Duks A; Laboratory of the State Agency Infection Centre, Virology Unit, Riga, Latvia.
  • Griskevicius A; National Public Health Surveillance Laboratory, Vilnius, Lithuania.
  • Johansen K; Swedish Institute for Infectious Disease Control, Stockholm, Sweden.
  • Bartha K; National Centre for Epidemiology, Budapest, Hungary.
  • Kriz B; National Institute of Public Health (SZU), Prague, Czech Republic.
  • Mitis G; Nicosia Hospital, Nicosia, Cyprus.
  • Mossong J; Surveillance & Epidemiology of Infectious Diseases, Laboratoire National de Santé, Luxembourg.
  • Nardone A; Health Protection Agency Health Protection Services Colindale, London, UK.
  • O'Flanagan D; Health Protection Surveillance Centre, Dublin, Ireland.
  • DE Ory F; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Pistol A; National Centre for Communicable Diseases Surveillance and Control, National Institute of Public Health, Romania.
  • Theeten H; Center for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Belgium.
  • Prosenc K; Laboratory for Virology, NPHI, Slovenia.
  • Slacikova M; Public Health Authority of the Slovak Republic, Bratislava, Slovak Republic.
  • Pebody R; Health Protection Agency Health Protection Services Colindale, London, UK.
Epidemiol Infect ; 141(3): 651-66, 2013 Mar.
Article em En | MEDLINE | ID: mdl-22687578
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacina contra Caxumba / Surtos de Doenças / Vacinação / Anticorpos Antivirais / Caxumba / Vírus da Caxumba Tipo de estudo: Incidence_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Epidemiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / EPIDEMIOLOGIA Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacina contra Caxumba / Surtos de Doenças / Vacinação / Anticorpos Antivirais / Caxumba / Vírus da Caxumba Tipo de estudo: Incidence_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Epidemiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / EPIDEMIOLOGIA Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Suécia